Detalles de la búsqueda
1.
A non-anhydrous, minimally basic protocol for the simplification of nucleophilic 18F-fluorination chemistry.
Sci Rep
; 10(1): 6818, 2020 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321927
2.
Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test.
Pharmacology
; 81(3): 229-35, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18176093
3.
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.
J Cereb Blood Flow Metab
; 14(6): 982-94, 1994 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-7929662
4.
Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Neuropsychopharmacology
; 17(3): 186-96, 1997 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9272485
5.
Central monoaminergic effects of two aporphine analogues to the putative serotonin-receptor agonist, 8-hydroxy-2-di-n-propylaminotetralin.
Neuropharmacology
; 23(10): 1187-90, 1984 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-6097834
6.
Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
Neuropharmacology
; 21(10): 953-61, 1982 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-6890636
7.
S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat.
Neuropharmacology
; 24(5): 391-9, 1985 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-4022264
8.
Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
Neuropharmacology
; 21(12): 1311-6, 1982 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-6891445
9.
R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.
Neuropharmacology
; 30(1): 97-9, 1991 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-1675452
10.
R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
Neuropharmacology
; 29(6): 527-36, 1990 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-1974710
11.
Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines.
Neuropharmacology
; 35(5): 549-70, 1996 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-8887963
12.
Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus.
Neuropharmacology
; 23(8): 885-92, 1984 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-6483116
13.
Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonist.
J Med Chem
; 26(10): 1348-53, 1983 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-6620296
14.
Isoquinolines. 5. Synthesis and antiarrhythmic activity of benzylisoquinoline derivatives.
J Med Chem
; 20(7): 894-8, 1977 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-874964
15.
Fluorescent probes for dopamine receptors: synthesis and characterization of fluorescein and 7-nitrobenz-2-oxa-1,3-diazol-4-yl conjugates of D-1 and D-2 receptor ligands.
J Med Chem
; 34(11): 3235-41, 1991 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-1956042
16.
2-Haloaporphines as potent dopamine agonists.
J Med Chem
; 32(6): 1198-201, 1989 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-2524592
17.
Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
J Med Chem
; 35(8): 1466-71, 1992 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-1533424
18.
Synthesis and receptor binding of N-substituted tropane derivatives. High-affinity ligands for the cocaine receptor.
J Med Chem
; 34(5): 1728-31, 1991 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-2033595
19.
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
J Med Chem
; 31(7): 1392-6, 1988 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-3385732
20.
(+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
J Med Chem
; 35(1): 67-72, 1992 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-1531075